I've been seeing a man regularly for the past year. We get along great and the chemistry is there – lots of love on both sides. However, I feel growing anger. I've been waiting for him to ask me to live with him or get married. I've been giving him plenty of hints but it's not working. I think he likes it the way it is. I don't want to lose him but the stress of waiting really affects my feelings. Why can’t I get him to act? How long should I wait?
Read More
If you have just been told that you may need to have a hysterectomy, what are you feeling? Frightened, uncertain, vulnerable, angry, out of control -- don't panic. I don't think anyone could have had any more of a negative reaction than I did when I was told, "you should probably think about having surgery."
Read More
Taboo Health Issue May Mean Needless Hysterectomy For Many
October 7th 2011More than 10 million American women suffer from excessive menstrual bleeding or heavy periods, a condition known as menorrhagia. In fact, more than 20 percent of the 600,000 hysterectomies performed annually in the United States treat menorrhagia. But because this health issue is so rarely discussed, few women realize that the condition can be easily treated during a 30-minute outpatient procedure as opposed to having a hysterectomy.
Read More
FDA Warns About Risks with Birth Control Pills Containing Drospirenone
October 6th 2011The FDA has not reached a definitive conclusion nor recalled contraception containing the hormone drospirenone. But on September 26, 2011, it told consumers and physicians that it is officially reviewing its safety.
Read More
Surgical Alternatives to Hysterectomy for Abnormal Uterine Bleeding
October 4th 2011The purpose of this report is to present physicians with several surgical alternatives to hysterectomy for women experiencing menorrhagia and dysfunctional uterine bleeding. Approximately 8700 hysterectomies are performed annually in Minnesota.
Read More
Poll: Do you recommend IUD's to patients who test positive for HPV to prevent cervical cancer?
October 4th 2011In a recent study, researchers found that, while the IUD did not protect HPV infection, it may impede the progression of HPV to cervical cancer. With this in mind would you recommend the use of an IUD to your patients who have tested positive for HPV in order to possibly prevent cervical cancer?
Read More
Theories of Fibroid Information
October 3rd 2011Despite the major public health impact of leiomyomas, little is known about their cause. Until recently, the steroid hormones estrogen and progesterone were considered the most important regulators of leiomyoma growth. There is abundant evidence that estrogen promotes fibroid growth including the clinical observations that fibroids grow in the presence of high levels of estrogen, such as during the reproductive years, and that they regress in the presence of low levels of estrogen, such as following menopause or during gonadotropin releasing hormone (GnRH) agonist therapy.
Read More
Overcoming Technical Limits to Laparoscopic Hysterectomy
October 3rd 2011The first laparoscopic hysterectomy was performed in 1989 by Henry Reich. Nowadays the laparoscopic hysterectomy for a uterus up to 300 grams, without other pathologies that could limit its mobility or without a poor vaginal access, has to be considered a basic well standardized procedure.
Read More
Preservation of Reproductive Function in the Female
September 30th 2011The female reproductive function depends on the healthy ovaries (primary reproductive organ) and genital tract organs. Infertility is one of the main gynecological problems which affect between 10-15% of females in the reproductive age.
Read More
Myomectomy is becoming a much more frequently performed procedure certainly it is one that is sought out much more frequently by our patients. Probably the most intimidating form of fibroids is that which occurs in the broad ligament, and particularly one which occurs in the cervical region.
Read More
Prediction of Treatment Outcomes After Global Endometrial Ablation
September 30th 2011To report rates of amenorrhea and treatment failure after global endometrial ablation and to estimate the association between patient factors and these outcomes by developing and validating prediction models.
Read More
The Papanicolaou (Pap) test is the best screening test we have in medicine. Countries that perform the test, like the USA, prevent over 90% of cervical cancers. Pap tests should not detect cervical cancer, because it is the cervical cancer we want prevent. Our goal is to detect pre-cancerous changes, and treat cases in their pre-cancerous state. Earlier findings require less costly and less painful treatment.
Read More
Significant Step in Cervical Cancer Screening
September 27th 2011The Society of Gynecologic Oncologists (SGO) has endorsed the American Cancer Society's (ACS) new guidelines, "Early Detection of Cervical Neoplasia and Cancer," released in the Nov./Dec. issue of CA: A Cancer Journal for Clinicians. The new guidelines represent a significant step forward in advising the health care community and the public on the importance of cervical cancer screening and the relationship between the Human Papillomavirus (HPV) virus and cervical cancer.
Read More
Incontinence linked to depression in nearly half of women
September 27th 2011Depression and incontinence appear to be associated in women, but the statistical strength of that association depends on the instrument used to classify depression, according to this population-based, cross-sectional study. Investigators used data on 5,701 women aged 50 to 69 years collected during interviews conducted for the Health and Retirement Study.
Read More
The National HPV & Cervical Cancer Campaign You Need to Know
September 26th 2011The National HPV & Cervical Cancer Campaign is a public education campaign whose goal is to reduce the number of preventable deaths each year by cervical cancer through increased education, outreach and communication between women and their health care providers.
Read More
Venous Thromboembolism and Estrogen Hormone Therapy: Patch Presents Less Risk Than Pill
September 25th 2011A new study provides a real-world snapshot of risks associated with venous thromboembolism in women receiving hormone replacement therapy, demonstrating that women who use an estradiol transdermal system may have less risk of developing thromboembolism than their counterparts who receive oral estrogen-only hormone therapy agents.
Read More
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer
September 23rd 2011Epithelial ovarian carcinoma claims more lives than any other gynecologic malignancy, largely because it frequently escapes detection after it has metastasized [1]. Ovarian carcinoma initially metastasizes primarily to the serosal surface of the peritoneal cavity and abdominal organs.
Read More
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1founder
September 23rd 2011Ovarian carcinomas from 30 BRCA1 germ-line carriers of two distinct high penetrant founder mutations, 20 carrying the 1675delA and 10 the 1135insA, and 100 sporadic cases were characterized for somatic mutations in the TP53 gene. We analyzed differences in relation to BRCA1 germline status, TP53 status, survival and age at diagnosis, as previous studies have not been conclusive.
Read More
Strategic Assessment of Cervical Cancer Prevention and Treatment Services in 3 Districts of India
September 23rd 2011Despite being a preventable disease, annually cervical cancer claims the lives of almost half a million women worldwide each year. India bears one-fifth of the global burden of the disease, with approximately 130,000 new cases a year.
Read More
Serum Levels of Vitamin A E B-Carotene and Folate in cases with Cervical Intraepithelial Neoplasia
September 23rd 2011A number of case-control and cohort studies have demonstrated a relationship between high intake of foods rich in carotenoids, Tocopherols, and vitamin C with a reduced risk of certain human malignancies.
Read More
Dysplastic changes in prophylactically removed Fallopian tubes of women inclined to ovarian cancer
September 23rd 2011The aim of this study was to investigate the occurrence of (pre)neoplastic lesions in overtly normal Fallopian tubes from women predisposed to developing ovarian carcinoma. The presence of (pre)neoplastic lesions was scored in histological specimens from 12 women with a genetically determined predisposition for ovarian cancer, of whom seven tested positive for a germline BRCA1 mutation.
Read More